Mural β3-integrin signposts Stroma6, a gene signature predicting early relapse in low-risk and chemoresistant breast cancer
Alex Jordan, Vimala Anthonydhason, Katie Baird, Eleni Maniati, Janet Louise Jones, Isobelle Wall, Anita E. Grigoriadis, Jun Wang, Tarek Abdelfatah, Kairbaan Hodivala‐Dilke
The paper identifies a 6-gene stromal signature, Stroma6, that predicts early relapse in low-risk and chemoresistant breast cancer patients, independent of Oncotype DX results.
bioRxiv · Sep 16, 2026 · PreprintCancer Biology